Humana Inc (HUM)

HUM (NYSE:Health Services) EQUITY
pos +0.00
Today's Range: 217.83 - 222.48 | HUM Avg Daily Volume: 1,443,100
Last Update: 04/28/17 - 4:02 PM EDT
Volume: 0
YTD Performance: 8.80%
Open: $0.00
Previous Close: $218.67
52 Week Range: $150.00 - $222.48
Oustanding Shares: 144,284,497
Market Cap: 31,550,690,959
6-Month Chart
TheStreet Ratings Grade for HUM
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 8
Moderate Buy 1 1 1 1
Hold 6 4 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.87 1.69 1.79 1.79
Latest Dividend: 0.40
Latest Dividend Yield: 0.73%
Dividend Ex-Date: 06/28/17
Price Earnings Ratio: 53.20
Price Earnings Comparisons:
HUM Sector Avg. S&P 500
53.20 53.70 29.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.08% 24.80% 103.71%
Revenue 11.90 0.00 0.00
Net Income -51.90 -0.50 -0.21
EPS -51.80 -0.50 -0.19
Earnings for HUM:
Revenue 54.38B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $2.55 $2.76 $11.06 $12.00
Number of Analysts 10 9 5 10
High Estimate $2.75 $2.81 $11.12 $12.50
Low Estimate $2.22 $2.72 $11.00 $11.50
Prior Year $1.86 $2.30 $9.57 $11.06
Growth Rate (Year over Year) 37.26% 19.90% 15.55% 8.49%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Clearing $220 will set the stage for insurer's move.
Apr 21, 2017 | 9:02 AM EDT
Humana was downgraded at Jefferies to "Hold" from "Buy" to with a $221 price target.
Their overseas business has been carrying them.
This reversal has been incredible to watch.
With a strong chart and indicators, shares are poised to make further new highs.

Health Care Putting in a Base Real Money Pro($)

Healthcare stocks had a heckuva four-year period of over-performance that ended in the summer of 2015. Since then the Health Care Select Sector SPDR ETF (XLV) (40% pharma and 15% biotech) has had a series of trading-range moves as sector prices lagged. Last year more than $18 billion was redeemed out of the healthcare ETFs, according to Morningstar. However there are some technical signposts that the two-year period of underperformance might be ending, as a basing seems likely. Look at the chart and note the recent higher high.
There are too many zero-sum games being portrayed as win-wins.
Bull market number one, perhaps of all time: the financials.
Feb 15, 2017 | 7:05 AM EST
Shares of HUM now seen reaching $220, according to Credit Suisse. Estimates also increased, as the company offered solid guidance, foll...
It looks like consolidation among the large health insurers is deader than a doornail. Anthem's (ANTH) $54 billion deal to buy Cigna (CI) was blocked by a federal judge yesterday. This follows a recent court-ordered halt that looks like it could derail the potential combination of Aetna (AET) and Humana (HUM) . There are a lot of unknowns about the overall health care market right now, as no one knows what will happen with the Affordable Care Act this year.


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.